This week’s research roundup features: Phase II randomized trial of transoral surgery and low-dose intensity Modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: An ECOG-ACRIN cancer research group trial (E3311).
This week’s research roundup features: Proceedings from the ice hockey summit III: Action on concussion.
This week’s research roundup features: Autopsy validation of progressive supranuclear palsy-predominant speech/language disorder criteria.
This week’s research roundup features: Effect of urate-elevating inosine on early Parkinson disease progression: The SURE-PD3 randomized clinical trial.
This week's research roundup features: Therapeutic trials in adult FSGS: lessons learned and the road forward.
This week's research roundup features: Effect of probiotics on incident ventilator-associated pneumonia in critically Ill patients: A randomized clinical trial.
This week's research roundup features: Performance assessment of DNA sequencing platforms in the ABRF Next-Generation Sequencing Study.
This weeks research roundup features: Thrombosis and inflammation may contribute to the risk of death and complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically ill patients who are hospitalized with Covid-19.
This weeks research roundup features Consensus-Based Recommendations on the prevention of squamous cell carcinoma in solid organ transplant recipients: A delphi consensus statement.
This weeks research roundup features Diagnosis and classification of ileal pouch disorders: consensus guidelines from the international Ileal pouch consortium.
This week's research roundup features Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with Ibrutinib.
This week's research roundup features therapeutic anticoagulation with heparin in noncritically ill patients with COVID-19.
This week's research roundup features the CLL international prognostic index predicts outcome in monoclonal B-cell lymphocytosis and rai 0 CLL.